from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3412/-

LFCtreatmentdescriptionclass of inhibitor

-1.220

Amikacinug/mL Amikacintranslation

-0.085

Cap5-10ug/mL Capreomycintranslation

-0.734

Rox10-50 ug/mL Roxithromycintranslation

0.797

SM2-5 ug/mL Streptomycintranslation

-0.751

Tet5-10 ug/mL Tetracyclinetranslation

-2.220

Rif0.2-5ug/mL Rifampicintranscription

-0.970

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.625

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.801

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.986

CPZ10-50 ug/mL Chlorpromazinerespiration

0.657

Clofazimine10-13 ug/mL Clofaziminerespiration

0.306

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.798

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.457

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.031

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.515

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.179

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.332

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.752

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.883

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.319

KCN5-20 ug/mL Potassium cyaniderespiration

0.522

NaN30.2-2 mM Sodium aziderespiration

0.735

Nigericin50 uM Nigericinrespiration

-0.694

TRC10-150 ug/mL Triclosanrespiration

0.118

TRZ10-25 ug/mL Thioridazinerespiration

-0.646

Valinomycin0.5-10 uM Valinomycinrespiration

0.414

ZnSO42 mM ZnSO4respiration

1.376

menadione6-10 ug/mL Menadionerespiration

0.727

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.048

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.511

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.083

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.314

NRP_1Non-replicating persistence stage 1dosRassociated

0.398

Amp0.2mg/mL AmpicillincellWall

-0.410

Cephalexin20-100 ug/mL CephalexincellWall

0.123

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.315

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.338

EMB10-20 ug/mL EthambutolcellWall

0.278

Eta12-40 ug/mL EthionamidecellWall

0.182

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.119

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.234

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.211

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.866

BZA0.12 mg/mL BenzamidearomaticAmides

-0.719

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.763

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.146

H2O24 mM hydrogen peroxideDNAdamaging

0.538

Levo10 ug/mL LevofloxacinDNAdamaging

0.309

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.916

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.106

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.016

UVUV-irradiationDNAdamaging

0.357

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.231

Antimycin12.5-50 ug/mL Antimycin A?

-0.383

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.116

PA_110-50 ug/mL Antitubercular compound PA-1?

0.060

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.165

PA8240.2-2 ug/mL PA-824?

0.191

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.587

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.402

Verapamil50 uM Verapamil?

-0.090

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.136

methoxatin10-20 ug/mL Methoxatin?